RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
暂无分享,去创建一个
A. Chambery | H. Stunnenberg | L. Altucci | A. Mai | G. Citro | A. Nebbioso | P. Bontempo | A. Baldi | E. Radaelli | R. Ragno | M. Zollo | Francesca Cuomo | V. Carafa | R. Russo | D. Rotili | G. Cobellis | D. Tarantino | P. Ciana | M. Ruvo | Jani Shaik | E. Spugnini | Adele Pirolli | Luca Maravigna | P. De Antonellis
[1] Mixed Lineage Kinase Domain-Like Protein , 2020, Definitions.
[2] A. Ballabio,et al. Molecular definitions of autophagy and related processes , 2017, The EMBO journal.
[3] A. Degterev,et al. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis. , 2017, Trends in pharmacological sciences.
[4] G. Brumatti,et al. Relevance of necroptosis in cancer , 2017, Immunology and cell biology.
[5] L. Galluzzi,et al. Necroptosis: Mechanisms and Relevance to Disease. , 2017, Annual review of pathology.
[6] Wei Li,et al. Post-translational modifications as key regulators of TNF-induced necroptosis , 2016, Cell Death and Disease.
[7] F. Dekker,et al. Histone acetyltransferases: challenges in targeting bi-substrate enzymes , 2016, Clinical Epigenetics.
[8] M. Lahtela-Kakkonen,et al. Sirtuin functions and modulation: from chemistry to the clinic , 2016, Clinical Epigenetics.
[9] L. Galluzzi,et al. Necrosis: Linking the Inflammasome to Inflammation. , 2015, Cell reports.
[10] Xu Guang Yan,et al. RIP1 Kinase Is an Oncogenic Driver in Melanoma. , 2015, Cancer research.
[11] A. Mai,et al. Sirtuin modulators: an updated patent review (2012 – 2014) , 2015, Expert opinion on therapeutic patents.
[12] T. Vanden Berghe,et al. Necroptosis, in vivo detection in experimental disease models. , 2014, Seminars in cell & developmental biology.
[13] D Andrews,et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 , 2014, Cell Death and Differentiation.
[14] P. Nordlund,et al. The cellular thermal shift assay for evaluating drug target interactions in cells , 2014, Nature Protocols.
[15] L. Komuves,et al. Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.
[16] Marjan Gucek,et al. The NAD-dependent deacetylase SIRT2 is required for programmed necrosis , 2012, Nature.
[17] S. Fulda,et al. RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis* , 2012, The Journal of Biological Chemistry.
[18] Sun-Hee Kim,et al. Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosis. , 2012, Biochemical pharmacology.
[19] H. Hase,et al. NEMO Inhibits Programmed Necrosis in an NFκB-Independent Manner by Restraining RIP1 , 2012, PloS one.
[20] Gerhard Christofori,et al. Molecular networks that regulate cancer metastasis. , 2012, Seminars in cancer biology.
[21] M. Capogrossi,et al. Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals , 2012, Molecular biology of the cell.
[22] Xiaodong Wang,et al. Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.
[23] L. Altucci,et al. Sirtuins and Disease: The Road Ahead , 2012, Front. Pharmacol..
[24] H. Stunnenberg,et al. Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008 , 2011, Molecular Cancer Therapeutics.
[25] A. Ashkenazi,et al. NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling , 2011, Cell.
[26] P. Vandenabeele,et al. Molecular mechanisms of necroptosis: an ordered cellular explosion , 2010, Nature Reviews Molecular Cell Biology.
[27] Junying Yuan,et al. Necroptosis as an alternative form of programmed cell death. , 2010, Current opinion in cell biology.
[28] Shi-Yong Sun. N-acetylcysteine, reactive oxygen species and beyond , 2010, Cancer biology & therapy.
[29] F. Chan,et al. Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.
[30] M. Bertrand,et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. , 2008, Molecular cell.
[31] Alexei Degterev,et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.
[32] W. Sippl,et al. Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins) , 2007, ChemMedChem.
[33] M. Parthun. Hat1: the emerging cellular roles of a type B histone acetyltransferase , 2007, Oncogene.
[34] Ruben Abagyan,et al. Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.
[35] A. Ting,et al. Ubiquitination of RIP1 regulates an NF-{kappa}B-independent cell death switch in TNF signaling. , 2007 .
[36] W. Yeh,et al. Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling , 2007, Current Biology.
[37] P. Vandenabeele,et al. RIP1, a kinase on the crossroads of a cell's decision to live or die , 2007, Cell Death and Differentiation.
[38] P. Distefano,et al. Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. , 2005, Journal of medicinal chemistry.
[39] R. Medema,et al. FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1* , 2004, Journal of Biological Chemistry.
[40] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[41] Steven P. Gygi,et al. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.
[42] Delin Chen,et al. Mammalian SIRT1 Represses Forkhead Transcription Factors , 2004, Cell.
[43] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[44] Myoung-Woo Lee,et al. The involvement of oxidative stress in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in HeLa cells. , 2002, Cancer letters.
[45] D. Goeddel,et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.
[46] P. Leder,et al. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.
[47] Samir Guglani. Death , 1890, The Lancet.
[48] L. Galluzzi,et al. Secondary Necrosis: Accidental No More. , 2017, Trends in cancer.
[49] M. Parthun. Histone acetyltransferase 1: more than just an enzyme? , 2013, Biochimica et biophysica acta.
[50] R. Abagyan,et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. , 2007, Science.
[51] L. Altucci,et al. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells , 2005, Nature Medicine.
[52] Lucia Altucci,et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.
[53] A. Maggi,et al. In vivo imaging of transcriptionally active estrogen receptors , 2003, Nature Medicine.